(Reuters Health) - The suspected cancer-fighting effects of the cheap diabetes drug metformin just got more backing from two new studies in the journal Diabetes Care.
(Reuters Health) - The suspected cancer-fighting effects of the cheap diabetes drug metformin just got more backing from two new studies in the journal Diabetes Care.